Ulcerative Colitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Ulcerative Colitis Clinical Trials Market Report Overview
The Ulcerative Colitis clinical trial market research report provides an overview of the Ulcerative Colitis Clinical trials scenario. This report provides top-line data relating to the clinical trials on Ulcerative Colitis and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. It provides prominent drugs for in-progress trials (based on the number of ongoing trials).
Key Regions | · North America
· Asia-Pacific · Europe · Middle East & Africa · South & Central America |
Key Countries | · The US
· Japan · Germany · Belgium · The UK · China · Canada · Italy · Poland · Netherlands |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · Pfizer Inc
· Takeda Pharmaceutical Co Ltd · AbbVie Inc · ICON Plc · Johnson & Johnson · Bristol-Myers Squibb Co · IQVIA Holdings Inc · Merck & Co Inc · Thermo Fisher Scientific Inc · Ferring Holding SA |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Ulcerative Colitis Clinical Trials Market Segmentation by Regions and Countries
The key regions in the Ulcerative Colitis clinical trials market are North America, Asia-Pacific, Europe, the Middle East & Africa, and South & Central America. Europe dominates the market as of June 2023.
As of June 2023, the US has the highest number of Ulcerative Colitis clinical trials. It is followed by Japan, Germany, Belgium, the UK, China, Canada, Italy, Poland, and the Netherlands.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of Ulcerative Colitis in Gastrointestinal clinical trials as of June 2023. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, France has the highest proportion of Ulcerative Colitis to Gastrointestinal clinical trials as of June 2023. Moreover, most of the clinical trials were conducted in the US.
Ulcerative Colitis Clinical Trials Analysis by Regions, 2023 (%)
For more regional insights into the Ulcerative Colitis clinical trials market, download a free report sample
Ulcerative Colitis Clinical Trials Market Segmentation by Sponsor Types
Out of them, the company sponsor type dominates the market in 2023. The other key sponsor types in the Ulcerative Colitis clinical trials market are institutions and the government.
Ulcerative Colitis Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
For more sponsor type insights into the Ulcerative Colitis clinical trials market, download a free report sample
Ulcerative Colitis Clinical Trials Market - Competitive Landscape
The leading sponsors in the Ulcerative Colitis clinical trials market are Pfizer Inc, Takeda Pharmaceutical Co Ltd, AbbVie Inc, ICON Plc, Johnson & Johnson, Bristol-Myers Squibb Co, IQVIA Holdings Inc, Merck & Co Inc, Thermo Fisher Scientific Inc, and Ferring Holding SA. Pfizer Inc led the Ulcerative Colitis clinical trials market in June 2023.
Ulcerative Colitis Clinical Trials Market Analysis by Sponsors, 2023 (%)
To know more about the leading sponsors in the Ulcerative Colitis clinical trials market, download a free report sample
Segments Covered in the Report
Ulcerative Colitis Clinical Trials Regional Outlook (2023)
- North America
- Asia-Pacific
- Europe
- Middle East & Africa
- South & Central America
Ulcerative Colitis Clinical Trials Country Outlook (2023)
- The US
- Japan
- Germany
- Belgium
- The UK
- China
- Canada
- Italy
- Poland
- Netherlands
Ulcerative Colitis Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type, and End point status
- The report reviews the top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended, and Withdrawn) with a reason for unaccomplishment
- The report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regard to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trial count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Takeda Pharmaceutical Co Ltd
AbbVie Inc
ICON Plc
Johnson & Johnson
Bristol-Myers Squibb Co
IQVIA Holdings Inc
Merck & Co Inc
Thermo Fisher Scientific Inc
Ferring Holding SA
Table of Contents
Frequently asked questions
-
Which is the leading region in the Ulcerative Colitis clinical trials market?
Europe is the leading region in the Ulcerative Colitis clinical trials market as of June 2023.
-
Which is the leading country in the Ulcerative Colitis clinical trials market?
The US is the leading country in the Ulcerative Colitis clinical trials market as of June 2023.
-
Which is the leading sponsor type in the Ulcerative Colitis clinical trials market?
Company is the leading sponsor type in the Ulcerative Colitis clinical trials market as of June 2023.
-
Who are the leading sponsors in the Ulcerative Colitis clinical trials market?
The leading sponsors in the Ulcerative Colitis clinical trials market are Pfizer Inc, Takeda Pharmaceutical Co Ltd, AbbVie Inc, ICON Plc, Johnson & Johnson, Bristol-Myers Squibb Co, IQVIA Holdings Inc, Merck & Co Inc, Thermo Fisher Scientific Inc, and Ferring Holding SA.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Ulcerative Colitis reports

